Do Not Convert Progesterone Capsules to Cream Formulation
You should not attempt to convert progesterone 100mg capsules into a cream formulation in a non-pharmacy setting, as this constitutes compounding that requires specialized pharmaceutical expertise, quality control, and regulatory oversight that is not available outside of licensed compounding pharmacies.
Critical Safety and Regulatory Concerns
Why This Is Problematic
The American Association of Clinical Endocrinologists explicitly warns that compounded progesterone preparations are not subjected to FDA oversight, vary widely in content, and lack standardization 1. This creates serious patient safety issues:
- Inconsistent dosing: Research demonstrates significant variability in hormone content within compounded formulations. Studies show progesterone levels in compounded products ranging from 90.8 to 135 mg in capsules and 93 to 118 mg/g in creams—even when the same dose was prescribed 2
- Lack of quality control: Variations exist not only between pharmacies but also within individual batches, including differences between top, middle, and bottom layers of cream containers 2
- Unregulated products: Over-the-counter progesterone creams are classified as supplements, meaning their contents are neither standardized nor regulated 1
Bioavailability and Absorption Issues
Converting oral capsules to topical cream fundamentally changes drug delivery and absorption:
- Transdermal progesterone produces significantly different pharmacokinetics compared to oral formulations 3
- A 40mg topical dose can produce similar systemic exposure to 200mg oral progesterone, demonstrating the unpredictability of transdermal absorption 3
- The "first-pass hepatic effect" differs dramatically between routes, affecting both efficacy and safety profiles 1
What You Should Do Instead
For Menopausal Hormone Therapy
If progesterone cream is clinically indicated, use FDA-approved commercial preparations rather than attempting conversion:
- Micronized progesterone (100-200 mg daily orally or 200 mg for 10-12 days/month) is FDA-approved and evidence-based 1
- Transdermal patches containing estradiol plus progestogen are commercially available and properly standardized 1
- Vaginal progesterone preparations (gel or suppositories) are available as regulated products if the transdermal route is preferred 1
Critical Caveats
The guideline evidence strongly discourages compounded hormone preparations because:
- They lack proven clinical benefits over FDA-approved alternatives 1
- Commercial preparations of bioidentical hormones (molecularly identical to human hormones) already exist under FDA oversight 1
- The risks of inconsistent dosing may outweigh any theoretical benefits 2
If Compounding Is Absolutely Required
Only a licensed compounding pharmacy should prepare such formulations, as they have:
- Proper equipment and pharmaceutical-grade excipients
- Quality control procedures and stability testing
- Training in proper compounding techniques
- Regulatory compliance and documentation
Do not attempt home conversion or manipulation of pharmaceutical products, as this poses significant risks of under-dosing, over-dosing, contamination, and instability 1, 2.